Story perspectives

Ethical Concerns Emerge in Guinea-Bissau Hepatitis B Trial

3/15/2026

Summary

Story summary

The hepatitis B vaccine trial in Guinea-Bissau vaccinates only half of newborns and experts deem it unethical due to informed-consent concerns and potential conflicts of interest.
The scrutiny centers on Health and Human Services Secretary Robert F. Kennedy Jr. and his oversight of the study.
Kennedy's administration has shifted focus away from mRNA COVID-19 vaccines amid political pressures, reflecting vaccine skepticism on his advisory committee and possible policy consequences.

1 of 1

Story summary

The hepatitis B vaccine trial in Guinea-Bissau vaccinates only half of newborns and experts deem it unethical due to informed-consent concerns and potential conflicts of interest.
The scrutiny centers on Health and Human Services Secretary Robert F. Kennedy Jr. and his oversight of the study.
Kennedy's administration has shifted focus away from mRNA COVID-19 vaccines amid political pressures, reflecting vaccine skepticism on his advisory committee and possible policy consequences.